Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,165,500
Total 13F shares
4,087,703
Share change
-674,016
Total reported value
$14,838,993
Put/Call ratio
157%
Price per share
$3.63
Number of holders
22
Value change
-$3,209,332
Number of buys
9
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q4 2020

As of 31 Dec 2020, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,087,703 shares. The largest 10 holders included Burrage Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, UBS OCONNOR LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GROUP ONE TRADING, L.P., ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and JANE STREET GROUP, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.